Malignant tumor, the leading cause of death worldwide, poses a serious threat to human
health. For decades, natural product has been proven to be an essential source for novel …

Cold atmospheric plasma (CAP) is a partially ionized gas that gains attention as a well‐
tolerated cancer treatment that can enhance anti‐tumor immune responses, which are …

Bispecific nanoparticles (NPs) are conjugated with two antibodies that enhance T cell
cytotoxicity by sequentially targeting CD3 and tumor-specific proteins. This interaction …

Immunotherapies, such as immune checkpoint inhibitors (ICIs) and chimeric antigen
receptor (CAR) T cells, have revolutionized the treatment of patients with advanced and …

Simple Summary Colorectal cancer remains a major health problem worldwide, with high
prevalence and mortality rates. Innovative approaches and advanced therapeutic anticancer …

Next‐generation cancer treatments are expected not only to target cancer cells but also to
simultaneously train immune cells to combat cancer while modulating the immune …

Immunogenic cell death (ICD) promotes the immune antitumor response via releasing
damage-associated molecular patterns (DAMPs) from dying tumor cells. The induction of …

Chemoimmunotherapy has anchored a new blueprint for cancer management. As a
burgeoning approach, immunotherapy has shifted the paradigm of traditional chemotherapy …

Cell death is closely related to various diseases, and monitoring and controlling cell death is
a promising strategy to develop efficient therapy. Aggregation-induced emission luminogens …

Cancer is a major cause of incidence rate and mortality worldwide. In recent years, cancer
immunotherapy has made great progress in the preclinical and clinical treatment of …